Physician profile
Benjamin Morgan
NPI 1538448873
$1,636.06
in general payments reported to CMS, 2019-2025
14 companies · $430 in 2025
The $430 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $626 · 2021: $32.32 · 2022: $177 · 2023: $123 · 2024: $59.22 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $600.00 | 2020 | |
| W. L. Gore & Associates, INC. | $397.97 | 2025 | Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Depuy Synthes Sales INC. | $149.89 | 2022 | |
| Smith+Nephew, INC. | $145.68 | 2019 | |
| Mayne Pharma Commercial LLC | $104.05 | 2023-2025 | |
| Abbvie INC. | $69.45 | 2022-2023 | |
| Evofem Biosciences, INC. | $50.08 | 2020-2024 | |
| Avion Pharmaceuticals | $27.43 | 2019-2021 | |
| Hologic Sales and Service, LLC | $23.49 | 2023 | Myosure Tissue Removal Device |
| Lupin INC. | $17.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.97 | 2025 | |
| Roche Diagnostics Corporation | $12.12 | 2019 | |
| Organon LLC | $11.89 | 2024 | |
| Allergan, INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.